Author:
Bobrov E. S.,Gorbunova A. Yu.,Sannikova E. P.,Gubaidullin I. I.,Ignatova O. M.,Kopaeva M. Yu.,Bulushova N. V.,Kozlov D. G.
Subject
Applied Microbiology and Biotechnology,Biochemistry
Reference26 articles.
1. Smekhova, I.E., Perova, Yu.M., and Turetskova, N.N., Equivalence of multicomponent drugs. In vitro method, Zdorov’e—Osnova Chel.
Potents.: Probl. Puti Ikh Resheniya, 2012, vol. 7, no. 2, p. 875.
2. Keith, C.T., Borisy, A.A., and Stockwell, B.R., Multicomponent therapeutics for networked systems. Nature reviews, Drug Discov., 2005, vol. 4, no. 1, pp. 71–78. https://doi.org/10.1038/nrd1609
3. Brandta, S.J., Götza, A., Tschöpa, M.H., and Müllera, T.D., Gut hormone polyagonists for the treatment of type 2 diabetes, Peptides, 2018, vol. 100, pp. 190–201. https://doi.org/10.1016/j.peptides.2017.12.021
4. Boer, G.A. and Holst, J.J., Incretin hormones and type 2 diabetes–mechanistic insights and therapeutic approaches, Biology, 2020, vol. 9, p. 473. https://doi.org/10.3390/biology9120473
5. Bailey, C.J., GIP analogues and the treatment of obesity diabetes, Peptides, 2020, vol. 125, p. 170202. https://doi.org/10.1016/j.peptides.2019.170202
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献